Methyl 1-(diphenylMethyl)-3-hydroxyazetidine-3-carboxylate, 98%, 100mg

4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 98%, 100mg

(3-Chloropyrazin-2-yl)methylamine, 95.0%, 1g

7-Hydroxy-2-naphthoic acid, 97%, 250mg

Methyl (S)-3-(4-bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoate, 98%, 250mg

N-[4-(chloromethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine hydrochloride, 95.0%, 500mg

Methyl Formate [Standard Material for GC]>99.5%(GC)5mL

Boc-Cycloleucine, 98.0%, 25g

(R)-1,1,1-Trifluoro-3-methyl-2-butylamine, 97.0%, 250mg

(1R,4S)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid, 95.0%, 250mg

tert-Butyl (4-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)carbamate, 95.0%, 250mg

Trimethylsilylmethanethiol>97.0%(GC)1mL

GC capillary column ROTI®Cap-1701, 15 m, 0.53 mm, 1.00 µm, 1 Piece(s)